tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TEVA Stock Latest News

Teva enters Tuznue license agreement with Prestige Biopharma
The FlyTeva enters Tuznue license agreement with Prestige Biopharma
2d ago
TEVA
Teva announces FDA approval of Uzedy for bipolar I disorder
PremiumThe Fly
Teva announces FDA approval of Uzedy for bipolar I disorder
12d ago
TEVA
Teva price target raised to $24 from $22 at BofA
PremiumThe Fly
Teva price target raised to $24 from $22 at BofA
13d ago
TEVA
Teva price target raised to $26 from $23 at JPMorgan
PremiumThe Fly
Teva price target raised to $26 from $23 at JPMorgan
19d ago
TEVA
Teva put volume heavy and directionally bearish
PremiumThe Fly
Teva put volume heavy and directionally bearish
27d ago
TEVA
Teva Pharmaceutical: Strategic Focus and Financial Stability Drive Buy Rating
PremiumRatingsTeva Pharmaceutical: Strategic Focus and Financial Stability Drive Buy Rating
27d ago
TEVA
Teva price target raised to $26 from $23 at UBS
Premium
The Fly
Teva price target raised to $26 from $23 at UBS
28d ago
TEVA
Teva announces presentation of data from survey of patients taking AUSTEDO XR
Premium
The Fly
Teva announces presentation of data from survey of patients taking AUSTEDO XR
1M ago
TEVA
Teva preesents 10 posters from its schizophrenia medicines portfolio
PremiumThe Fly
Teva preesents 10 posters from its schizophrenia medicines portfolio
1M ago
TEVA
Riot, D-Wave, AmEx, Lowe’s, Teva: Stock Shake-Up!
PremiumWeekend Updates
Riot, D-Wave, AmEx, Lowe’s, Teva: Stock Shake-Up!
1M ago
AXP
LOW
Teva’s emrusolmin granted U.S. FDA Fast Track designation
PremiumThe Fly
Teva’s emrusolmin granted U.S. FDA Fast Track designation
1M ago
TEVA
Teva announces FDA approval, launch of Generic Saxenda
PremiumThe Fly
Teva announces FDA approval, launch of Generic Saxenda
2M ago
TEVA
Acadia Pharmaceuticals names Katcheves Chief Business and Strategy Officer
PremiumThe FlyAcadia Pharmaceuticals names Katcheves Chief Business and Strategy Officer
2M ago
ACAD
TEVA
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
GS, BAC, LEN: Billionaire Investor Stanley Druckenmiller Buys Bank and Housing Stocks
Premium
Market News
GS, BAC, LEN: Billionaire Investor Stanley Druckenmiller Buys Bank and Housing Stocks
2M ago
BAC
DAL
Teva announces U.S. FDA has approved AJOVY for preventive treatment
PremiumThe Fly
Teva announces U.S. FDA has approved AJOVY for preventive treatment
3M ago
TEVA
Teva Pharmaceuticals Reports Improved Earnings Amid Strategic Focus
PremiumCompany Announcements
Teva Pharmaceuticals Reports Improved Earnings Amid Strategic Focus
3M ago
TEVA
Teva’s Earnings Call Highlights Strong Innovative Growth
PremiumCompany Announcements
Teva’s Earnings Call Highlights Strong Innovative Growth
3M ago
TEVA
Teva management to meet with Truist
PremiumThe Fly
Teva management to meet with Truist
3M ago
TEVA
Teva says targeting operating margin of 30% by 2027
PremiumThe FlyTeva says targeting operating margin of 30% by 2027
3M ago
TEVA
Teva says ‘very confident’ about growing generics business
Premium
The Fly
Teva says ‘very confident’ about growing generics business
3M ago
TEVA
Teva reaffirms FY25 revenue view $16.8B-$17.2B, consensus $16.92B
Premium
The Fly
Teva reaffirms FY25 revenue view $16.8B-$17.2B, consensus $16.92B
3M ago
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >